Cao H, Wu Z, Zhou J, Chen Z, Kuang Y
Department of Surgery, Ren Ji Hospital, Shanghai Second Medical University, Shanghai 200001, China.
Chin Med J (Engl). 1999 Jun;112(6):516-9.
To evaluate the effects of nitric oxide inhibitor on prostacyclin (PGI2) biosynthesis and the role of PGI2 in hyperhemodynamics of portal hypertension.
Sprague Dawley rats were divided into four groups: intrahepatic portal hypertension (IHPH) by injection of CCl4, prehepatic portal hypertension (PHPH) by stenosis of the portal vein, end-to-side portacaval shunt (PCS), and sham-operated controls (SO). Animals of each group were subdivided into 2 groups: systemic administration of nitric oxide inhibitor L-NMMA and vehicle. The radioactive microsphere method was used for hemodynamic study. The level of plasma PGI2 (6-keto-PGF1 alpha) was measured by radioimmunoassay.
The characteristics of hyperdynamic circulatory state including increased cardiac output and splanchnic blood flow, decreased mean arterial blood pressure, total peripheral vascular resistance, and splanchnic vascular resistance were observed in IHPH, PHPH and PCS rats. The magnitude of hyperhemodynamics was in the order of PCS > PHPH > IHPH rats. The hyperdynamic circulatory state in IHPH, PHPH and PCS rats could be effectively reversed by L-NMMA to the baseline values of hemodynamics in SO rats. The baseline concentrations of plasma 6-keto-PGF1 alpha (ng/ml) in PHPH, IHPH, PCS, and SO rats were 6.93 +/- 2.43, 5.09 +/- 2.27, 2.36 +/- 1.01 and 1.56 +/- 0.61, respectively. The concentrations of plasma 6-Keto-PGF1 alpha in PHPH, IHPH and PCS rats were significantly higher than those in SO rats. Moreover, the concentrations were significantly higher in PHPH and IHPH rats than in PCS rats (P < 0.05). After administration of L-NMMA, the concentrations of plasma 6-Keto-PGF1 alpha (ng/ml) in PHPH, IHPH, PCS and SO rats were 7.69 +/- 2.98, 5.68 +/- 2.66, 5.50 +/- 0.79, 5.02 +/- 2.86, respectively. As compared to the baseline value, the concentrations of 6-keto-PGF1 alpha rats were slightly increased in IHPH, PHPH rats (P > 0.05), but significantly increased in PCS and SO rats (P < 0.05).
In this study, the hyperdynamic circulatory state in portal hypertensive rats and portacaval shunt rats was completely reversed by L-NNMA to normal, but the level of 6-keto-PGF1 alpha was still elevated. The results indicate that PGI2 is not involved in hyperhemodynamics of portal hypertension.
评估一氧化氮抑制剂对前列环素(PGI2)生物合成的影响以及PGI2在门静脉高压高血流动力学中的作用。
将Sprague Dawley大鼠分为四组:通过注射四氯化碳诱导肝内门静脉高压(IHPH)组、通过门静脉狭窄诱导肝前门静脉高压(PHPH)组、端侧门腔分流术(PCS)组和假手术对照组(SO)。每组动物再分为两组:全身给予一氧化氮抑制剂L-NMMA组和给予赋形剂组。采用放射性微球法进行血流动力学研究。通过放射免疫分析法测定血浆PGI2(6-酮-PGF1α)水平。
在IHPH、PHPH和PCS大鼠中观察到高动力循环状态的特征,包括心输出量和内脏血流量增加、平均动脉血压、总外周血管阻力和内脏血管阻力降低。高血流动力学的程度依次为PCS>PHPH>IHPH大鼠。L-NMMA可有效将IHPH、PHPH和PCS大鼠的高动力循环状态逆转至SO大鼠的血流动力学基线值。PHPH、IHPH、PCS和SO大鼠血浆6-酮-PGF1α的基线浓度(ng/ml)分别为6.93±2.43、5.09±2.27、2.36±1.01和1.56±0.61。PHPH、IHPH和PCS大鼠血浆6-酮-PGF1α的浓度显著高于SO大鼠。此外,PHPH和IHPH大鼠的浓度显著高于PCS大鼠(P<0.05)。给予L-NMMA后,PHPH、IHPH、PCS和SO大鼠血浆6-酮-PGF1α的浓度(ng/ml)分别为7.69±2.98、5.68±2.66、5.50±0.79、5.02±2.86。与基线值相比,IHPH、PHPH大鼠6-酮-PGF1α的浓度略有升高(P>0.05),但PCS和SO大鼠显著升高(P<0.05)。
在本研究中,L-NNMA可将门静脉高压大鼠和门腔分流大鼠的高动力循环状态完全逆转至正常,但6-酮-PGF1α水平仍升高。结果表明PGI2不参与门静脉高压的高血流动力学。